Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-300
Closed -$31.4K 642
2023
Q1
$31.4K Buy
300
+1
+0.3% +$104 0.01% 157
2022
Q4
$33.1K Buy
299
+1
+0.3% +$105 0.02% 146
2022
Q3
$26K Buy
298
+1
+0.3% +$91 0.01% 153
2022
Q2
$23K Buy
297
+1
+0.3% +$83 0.01% 178
2022
Q1
$25K Buy
296
+1
+0.3% +$96 0.03% 160
2021
Q4
$35K Buy
295
+1
+0.3% +$124 0.03% 156
2021
Q3
$36K Hold
294
0.03% 158
2021
Q2
$35K Buy
294
+1
+0.3% +$114 0.03% 154
2021
Q1
$31K Buy
293
+1
+0.3% +$101 0.03% 148
2020
Q4
$30K Buy
+292
New +$27.4K 0.03% 141

Other funds holding XYL

Syverson Strege & Co's XYL Position: Q2 2023 in Review

Syverson Strege & Co sold out of Xylem (XYL) in Q2 2023, closing a stake of 300 shares — an estimated $31.4K sold.

Syverson Strege & Co first reported a position in XYL in Q4 2020 and held it in 10 quarters. The position peaked at $36K in Q3 2021. 908 funds tracked by Wall St. Rank hold XYL as of Q2 2023.

  • Syverson Strege & Co reported no remaining Xylem position as of Q2 2023 after selling out during the quarter.
  • Syverson Strege & Co sold 300 Xylem shares in Q2 2023, an estimated $31.4K.
  • Syverson Strege & Co first reported a position in Xylem in Q4 2020 and held it in 10 quarters.
  • Syverson Strege & Co's Xylem position peaked at $36K in Q3 2021.
  • 908 funds tracked by Wall St. Rank held Xylem as of Q2 2023.

Based on Syverson Strege & Co's 13F filing for Q2 2023, filed 4 Aug 2023.